Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK 208141 for Herpes Simplex Prophylaxis
NCT00698490Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 1995
- Primary completion
- Jan 1997
- Modality
- Viral Vector Vaccines, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Simplirix in herpes simplex (HSV), sponsored by GSK. Started Aug 1995; status: completed.
02
Drugs
Simplirix
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on NCT00698490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698490.